THEMATICS - GENETIC THERAPIES

SEC insider activity covers quarterly filings through June 30, 2026. Later filings are not included. Reported roles do not establish current employment or current holdings. SEC filing documents, sections and filing-text search cover filings dated January 1, 2000 onward. Earlier filings are deferred until after launch.

organization

Jurisdiction: LULegal Form: UDY2

ACTIVE

LEI: 549300HCKFQUEXP2QU08

Summary

THEMATICS - GENETIC THERAPIES is an organization. It is a subsidiary of JPMorgan Asset Management (Europe) S.à r.l..

Legal entity: GLEIF